Evofem Biosciences, Inc. (EVFM) |
| 0.01291 0.001 (8.31%) 10-10 15:57 |
| Open: | 0.0122 |
| High: | 0.013 |
| Low: | 0.012 |
| Volume: | 895,341 |
| Market Cap: | 2(M) |
| PE Ratio: | -0.22 |
| Exchange: | Other OTC |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.04 |
| Resistance 1: | 0.03 |
| Pivot price: | 0.02 |
| Support 1: | 0.01 |
| Support 2: | 0.01 |
| 52w High: | 0.016 |
| 52w Low: | 0.006 |
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Financials
| EPS | -1.400 |
| Book Value | -0.760 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.058 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 01 Oct 2025
Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates (2025-10-01) - Seeking Alpha
Wed, 01 Oct 2025
1.7M UAE Women Could Benefit: Evofem's Single-Dose BV Treatment Seeks First International Approval - Stock Titan
Fri, 26 Sep 2025
First-Ever Hormone-Free On-Demand Birth Control: Evofem's PHEXXI Transforms Contraception Options - Stock Titan
Fri, 26 Sep 2025
Evofem Biosciences Honors World Contraception Day - PR Newswire
Tue, 09 Sep 2025
Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting - PR Newswire
Tue, 19 Aug 2025
FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
